Impressive Results from ITCC-059 Trial of Inotuzumab Ozogamicin – Princess Máxima Center
Prinses Máxima Centrum voor kinderoncologie (Princess Máxima Center) shared on LinkedIn: “The targeted drug inotuzumab ozogamicin has been…
Browsing Category